Physician profile
Malik Megjhani
NPI 1023354800
$2,401.44
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,940 · 2020: $425 · 2021: $36.75.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $449.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.25 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $265.19 | 2019-2020 | |
| Novo Nordisk INC | $243.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $224.37 | 2019-2020 | |
| Lilly USA, LLC | $201.75 | 2019-2020 | |
| Amarin Pharma, INC. | $133.22 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.86 | 2019-2020 | |
| Glaxosmithkline, LLC. | $98.69 | 2019-2020 | |
| Philips North America LLC | $89.14 | 2019-2021 | |
| Pfizer INC. | $71.64 | 2019-2020 | |
| Allergan, INC. | $50.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.71 | 2019-2020 | |
| Pharming Healthcare, INC. | $28.59 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $18.95 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.59 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.10 | 2020 | |
| Horizon Therapeutics Plc | $12.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malik Megjhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.